Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
China flag China · Delayed Price · Currency is CNY
2.920
-0.020 (-0.68%)
Jun 2, 2026, 3:04 PM CST

SHE:002589 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
5,0503,7454,9845,0615,3404,579
Cash & Short-Term Investments
5,0503,7454,9845,0615,3404,579
Cash Growth
1.51%-24.87%-1.52%-5.23%16.63%-20.97%
Accounts Receivable
4,0414,1764,3754,2224,60311,276
Other Receivables
703.3717.08893.29990.011,6701,897
Receivables
4,7454,8935,2695,2126,27413,172
Inventory
651.64715.3734.741,119954.512,068
Prepaid Expenses
---0.11-7.27
Other Current Assets
158.7100.4296.79147.07250.97845.88
Total Current Assets
10,6059,45311,08411,53912,82020,672
Property, Plant & Equipment
2,0152,0182,2392,2772,2972,527
Long-Term Investments
921.33821.33746.72852.03594.07805.82
Goodwill
146.67146.67146.67146.67146.69620.27
Other Intangible Assets
482.79506.7440.89552.39624.21478.35
Long-Term Accounts Receivable
-----0.07
Long-Term Deferred Tax Assets
317.38321.59286.15284.44106.68122.86
Long-Term Deferred Charges
48.0949.6961.2660.8789.93134.58
Other Long-Term Assets
1,0111,0531,033996.391,6541,035
Total Assets
15,54714,37016,03816,70918,33226,397
Accounts Payable
4,5803,7603,3833,7237,7159,791
Accrued Expenses
14.8638.9543.0366.9857.68227.5
Short-Term Debt
4,6124,2016,0976,5563,9264,440
Current Portion of Long-Term Debt
27.53167.83155.385.66.516.3
Current Portion of Leases
-0.860.760.521.8210.09
Current Income Taxes Payable
13.621.523.641.68591.82
Current Unearned Revenue
14.999.4425.1329.1232.43174.72
Other Current Liabilities
392.47482.59237.28378.53724.461,766
Total Current Liabilities
9,6568,6629,94510,76112,46816,508
Long-Term Debt
397.86234.71327.08261.2767.248.5
Long-Term Leases
1.520.934.120.842.7339.19
Long-Term Unearned Revenue
4.534.574.741.621.9317.5
Long-Term Deferred Tax Liabilities
41.8944.9648.547.4840.5883.56
Other Long-Term Liabilities
-----7.28
Total Liabilities
10,1028,94710,32911,07212,58116,704
Common Stock
1,5051,5051,5051,5051,5051,505
Additional Paid-In Capital
3,4833,4773,6343,7203,7014,015
Retained Earnings
429.96419.59409.44453.83432.662,278
Treasury Stock
-101.48-101.48--230.65-230.65-230.65
Total Common Equity
5,3165,3005,5485,4485,4077,567
Minority Interest
128.36123.11160.2189.183442,126
Shareholders' Equity
5,4455,4235,7095,6375,7519,693
Total Liabilities & Equity
15,54714,37016,03816,70918,33226,397
Total Debt
5,0394,6056,5846,8244,0044,544
Net Cash (Debt)
10.8-860.3-1,600-1,7641,33634.82
Net Cash Growth
----3737.34%-
Net Cash Per Share
0.01-0.54-1.30-1.170.900.02
Filing Date Shares Outstanding
1,4701,4701,5051,4961,4961,496
Total Common Shares Outstanding
1,4701,4701,5051,4961,4961,496
Working Capital
948.8791.181,140777.98351.124,164
Book Value Per Share
3.623.613.693.643.615.06
Tangible Book Value
4,6874,6464,9614,7494,6366,468
Tangible Book Value Per Share
3.193.163.303.173.104.32
Buildings
-1,8211,9741,8191,8651,468
Machinery
-602.5687.24695.38778.651,436
Construction In Progress
-306.18307.34429.34315.37549.58